Gara Jalqabaatti › Dhukkubaa Harkaa Steatotic › Louisiana
Qorannoo klinikaalii Dhukkubaa Harkaa Steatotic Louisiana keessatti
Qorannoo 11 Dhukkubaa Harkaa Steatotic f Louisiana keessatti hirmaatuu jiru.
Magaalota Louisiana keessatti
- New OrleansQorannoo 8
- MonroeQorannoo 5
- MetairieQorannoo 4
- HoumaQorannoo 3
- ShreveportQorannoo 3
- LafayetteQorannoo 3
Takkalaa qorannoo (Ingiliffa)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Lafayette
- 89bio Clinical Study Site, Lake Charles
- 89bio Clinical Study Site, West Monroe
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Covington
- 89bio Clinical Study Site, Houma
- 89bio Clinical Study Site, Lake Charles
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06318169A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Tandem Clinical Research, Plaza II, Metairie
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07527910A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Tandem Clinical Research, Metairie
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Delta Research Partners of Bastrop, LLC, Bastrop
- Tandem Clinical Research, Marrero
- Care Access - New Iberia, New Iberia
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Bastrop
- Akero Clinical Study Site, Covington
- Akero Clinical Study Site, Houma
- fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Marrero
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Tandem Clinical Research, Covington
- Tandem Clinical Research, Houma
- Tandem Clinical Research GI, LLC, Marrero
- fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07288138A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Marrero
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Bastrop
- GSK Investigational Site, Marrero
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT07221227A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Tandem Clinical Research, Marrero
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT05648214Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.